Federal Circuit Slams Purdue With Inequitable Conduct Finding In OxyContent Patent Suit
By Marius Meland · June 7, 2005, 12:00 AM EDT
In a major setback for Purdue Pharma, Endo Pharmaceutical Holdings Inc. has won an appeals court ruling allowing it to sell a generic version of the painkiller OxyContin....
To view the full article, register now.